Hematopoietic Stem Cell TransplantationTransplantation, AutologousStem Cell TransplantationTransplantation, HomologousTransplantation ConditioningPeripheral Blood Stem Cell TransplantationHematopoietic Stem CellsStem CellsMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMelphalanGraft vs Host DiseaseTreatment OutcomeCombined Modality TherapyHematologic NeoplasmsLymphomaLymphoma, Non-HodgkinBone Marrow TransplantationRemission InductionSalvage TherapyHodgkin DiseaseDisease-Free SurvivalCyclophosphamideRecurrenceEtoposideHematopoietic Stem Cell MobilizationMyeloablative AgonistsSurvival RateRetrospective StudiesTransplantationCytarabineAntigens, CD34Lymphoma, FollicularTissue DonorsHistocompatibility TestingLymphoma, B-CellCarmustineSurvival AnalysisStem Cell NicheLymphoma, Mantle-CellBone Marrow PurgingVincristineWhole-Body IrradiationGraft SurvivalThiotepaLymphoma, Large B-Cell, DiffuseTransplantation ChimeraFollow-Up StudiesCell DifferentiationBusulfanAdult Stem CellsHematopoiesisAmyloidosisImmunocompromised HostPrognosisImmunosuppressive AgentsHepatic Veno-Occlusive DiseaseLymphoma, T-Cell, PeripheralDoxorubicinEmbryonic Stem CellsAntibodies, Monoclonal, Murine-DerivedBoronic AcidsMesenchymal Stem Cell TransplantationPyrazinesLeukemiaDexamethasoneTime FactorsAntineoplastic AgentsThalidomideAntineoplastic Agents, AlkylatingKidney TransplantationGranulocyte Colony-Stimulating FactorBone MarrowAutograftsPrednisoneCell LineageBone Marrow CellsIfosfamideLiver TransplantationCord Blood Stem Cell TransplantationLeukapheresisFlow CytometryInduction ChemotherapyLeukemia, Myeloid, AcutePluripotent Stem CellsMice, Inbred C57BLHLA AntigensPancytopeniaAnemia, AplasticCell TransplantationPodophyllotoxinLymphoma, T-CellCells, CulturedNeoplasm, ResidualHistocompatibilityFatal OutcomeCytomegalovirus InfectionsMaintenance ChemotherapyMyelodysplastic SyndromesNeural Stem Cells